Devices score one out of eleven in NICE (UK National Institute for Clinical Excellence) eighth work programme
This article was originally published in Clinica
Executive Summary
The UK National Institute for Clinical Excellence (NICE) is considering appraising dual-chamber pacing in elderly patients, as part of the institute's eighth work programme, which went out last week for consultation. This is, however, the only device- or diagnostic-related product appraisal planned, out of a total of 11 projects, suggesting that more needs to be done to raise the profile and needs of the medical devices industry.
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.